Gen-Probe's Q3 Revenues Inch Up 1 Percent

Revenues rose slightly as clinical diagnostic sales offset weakness in its blood screening business.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.